scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF02034935 |
P698 | PubMed publication ID | 1905530 |
P2093 | author name string | G G Gibson | |
F W Bonner | |||
J M Makowska | |||
P2860 | cites work | Cytoplasmic dot hybridization. Simple analysis of relative mRNA levels in multiple small cell or tissue samples | Q70403048 |
Clobuzarit: species differences in the morphological and biochemical response of the liver following chronic administration | Q70472992 | ||
Studies on the hepatomegaly caused by the hypolipidemic drugs nafenopin and clofibrate | Q70476497 | ||
[Morphometric study of hepatic peroxisomes in hyperlipoproteinemic patients treated with fenofibrate] | Q71421033 | ||
Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients | Q71702005 | ||
Relationship between morphological changes and lipid-lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man | Q71702041 | ||
The effects of phenobarbitone on urinary 6 beta-hydroxycortisol excretion and hepatic enzyme activity in the marmoset monkey (Callithrix jacchus) | Q72086929 | ||
The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid | Q72529908 | ||
Species differences in the metabolic conjugation of clofibric acid and clofibrate in laboratory animals and man | Q72552912 | ||
INFLUENCE OF THYROID HORMONES ON L-ALPHA-GLYCEROPHOSPHATE DEHYDROGENASES AND OTHER DEHYDROGENASES IN VARIOUS ORGANS OF THE RAT | Q78328488 | ||
Enhanced oxidation of alpha-glycerophosphate by mitochondria of thyroid-fed rats | Q78819297 | ||
Protein measurement with the Folin phenol reagent | Q20900776 | ||
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 | ||
Purification and properties of human erythrocyte glutathione peroxidase | Q28623182 | ||
Induction of hepatic peroxisome proliferation in nonrodent species, including primates | Q28762326 | ||
THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE | Q29547810 | ||
Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): species differences and possible mechanisms | Q34659166 | ||
Microbodies in experimentally altered cells. IV. Acatalasemic (CSb) mice treated with CPIB | Q36190561 | ||
Differential splicing in the 3' non-coding region of rat cytochrome P-452 (P450 IVA1) mRNA. | Q36455104 | ||
Absorption and disposition of 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid, WIN 35,833, in rats, monkeys, and men | Q39067626 | ||
Characteristics of a microsomal cytochrome P-448-mediated reaction. Ethoxyresorufin O-de-ethylation | Q39136222 | ||
The colorimetric estimation of formaldehyde by means of the Hantzsch reaction | Q39224472 | ||
The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney | Q39642120 | ||
Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to Humans | Q40165965 | ||
Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man. | Q40320085 | ||
Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB) | Q41082547 | ||
Microsomal cytochrome P-452 induction and peroxisome proliferation by hypolipidaemic agents in rat liver. A mechanistic inter-relationship | Q41435332 | ||
Fatty acid oxidation by human liver peroxisomes | Q41723750 | ||
Blood levels, tissue distribution and the duration of action in rats of ciprofibrate, a new hypolipidemic agent | Q41866343 | ||
Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver. | Q42259341 | ||
Tissue fractionation studies. 13. Analysis of mitochondrial fractions from rat liver by density-gradient centrifuging | Q42950447 | ||
Effect of clofibrate application on morphology and enzyme content of liver peroxisomes | Q45195624 | ||
Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset | Q46322850 | ||
A rapid microfluorimetric determination of monoamine oxidase | Q46798910 | ||
The carcinogenicity of dietary di(2-ethylhexyl) phthalate (DEHP) in Fischer 344 rats and B6C3F1 mice | Q48887839 | ||
Urate oxidase in primate phylogenesis. | Q51685170 | ||
Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: a biochemical human hazard assessment. | Q51834094 | ||
Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet. | Q53572901 | ||
Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens | Q59072082 | ||
Co-induction of microsomal cytochrome P-452 and the peroxisomal fatty acid β-oxidation pathway in the rat by clofibrate and di-(2-ethylhexyl)phthalate | Q68307968 | ||
A rapid spectrophotometric assay for carnitine palmitoyltransferase | Q69380299 | ||
Hepatic peroxisomal changes induced by a tetrazole-substituted alkoxyacetophenone in rats and comparison with other species | Q69611256 | ||
Comparison of the short-term effects of di(2-ethylhexyl) phthalate, di(n-hexyl) phthalate, and di(n-octyl) phthalate in rats | Q70046553 | ||
Specificity in the action of hypolipidemic drugs: increase of peroxisomal beta-oxidation largely dissociated from hepatomegaly and peroxisome proliferation in the rat | Q70348186 | ||
P433 | issue | 2 | |
P304 | page(s) | 106-113 | |
P577 | publication date | 1991-01-01 | |
P1433 | published in | Archives of Toxicology | Q635837 |
P1476 | title | Comparative induction of cytochrome P450IVA1 and peroxisome proliferation by ciprofibrate in the rat and marmoset | |
P478 | volume | 65 |
Q73445710 | Chemiluminescence and antioxidant levels during peroxisome proliferation by fenofibrate |
Q77449468 | Ciprofibrate--racemate and enantiomers: effects of a four-week treatment on male inbred Fischer rats. A biochemical and morphological study |
Q73740461 | Effect of extracellular matrix on the expression of peroxisome proliferation associated genes in cultured rat hepatocytes |
Q34734778 | Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk |
Q51630549 | Marmoset cytochrome P450 4A11, a novel arachidonic acid and lauric acid ω-hydroxylase expressed in liver and kidney tissues. |
Q41308256 | Non-genotoxic hepatocarcinogenesis: suppression of apoptosis by peroxisome proliferators |
Q33639751 | Regulation of endoplasmic reticulum biogenesis in response to cytochrome P450 overproduction |
Q36059868 | Role of oxidative stress in peroxisome proliferator-mediated carcinogenesis |
Q46775567 | Single and chronic administration of ciprofibrate or of ciprofibrate-glycinate in male Fischer 344 rats: comparison of the effects on morphological and biochemical parameters in liver and blood. |
Q53852086 | Species differences in ciprofibrate induction of hepatic cytochrome p450 4A1 and peroxisome proliferation |
Q40892752 | Species differences in peroxisome proliferation; mechanisms and relevance. |
Q24528146 | Species-specific induction of cytochrome P-450 4A RNAs: PCR cloning of partial guinea-pig, human and mouse CYP4A cDNAs |
Q33643158 | The perturbation of apoptosis and mitosis by drugs and xenobiotics |
Search more.